Chugai Pharmaceutical Co Ltd
TSE:4519

Watchlist Manager
Chugai Pharmaceutical Co Ltd Logo
Chugai Pharmaceutical Co Ltd
TSE:4519
Watchlist
Price: 7 130 JPY 0.01% Market Closed
Market Cap: 11.7T JPY
Have any thoughts about
Chugai Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Chugai Pharmaceutical Co Ltd stock under the Base Case scenario is 3 964.6 JPY. Compared to the current market price of 7 130 JPY, Chugai Pharmaceutical Co Ltd is Overvalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
3 964.6 JPY
Overvaluation 44%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
11
vs Industry
16
Median 3Y
6
Median 5Y
7.7
Industry
2.6
Forward
10.3
vs History
38
vs Industry
16
Median 3Y
21.9
Median 5Y
27
Industry
23
Forward
30.6
vs History
34
vs Industry
19
Median 3Y
22.4
Median 5Y
26.4
Industry
17.8
vs History
52
vs Industry
16
Median 3Y
30.4
Median 5Y
37.1
Industry
25.4
vs History
22
vs Industry
12
Median 3Y
5
Median 5Y
5.7
Industry
2.2
vs History
14
vs Industry
15
Median 3Y
5.5
Median 5Y
7.2
Industry
2.8
Forward
9.6
vs History
20
vs Industry
14
Median 3Y
9
Median 5Y
11.3
Industry
5.4
vs History
41
vs Industry
19
Median 3Y
14
Median 5Y
18.1
Industry
13.7
Forward
19.9
vs History
42
vs Industry
21
Median 3Y
14
Median 5Y
19
Industry
17.2
vs History
33
vs Industry
21
Median 3Y
20.6
Median 5Y
24.7
Industry
16.5
vs History
52
vs Industry
16
Median 3Y
26.8
Median 5Y
33.1
Industry
19.3
vs History
9
vs Industry
11
Median 3Y
6.1
Median 5Y
7.3
Industry
2

Multiples Across Competitors

Competitors Multiples
Chugai Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Chugai Pharmaceutical Co Ltd
TSE:4519
11.7T JPY 10.3 30.3 19.2 20.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Chugai Pharmaceutical Co Ltd
TSE:4519
Average P/E: 32.9
30.3
32%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top